Deep Track Capital, LP has filed its 13F form on November 14, 2024 for Q3 2024 where it was disclosed a total value porftolio of $2.71 Billion distributed in 71 stocks.
Among their holdings, we can observe that their the top five positions include companies like: Argenx Se with a value of $198M, Dynavax Technologies Corp with a value of $140M, Guardant Health, Inc. with a value of $138M, Apellis Pharmaceuticals, Inc. with a value of $127M, and Spring Works Therapeutics, Inc. with a value of $123M.
Examining the 13F form we can see an decrease of $335M in the current position value, from $3.05B to 2.71B.
Deep Track Capital, LP is based out at Greenwich, CT
Below you can find more details about Deep Track Capital, LP portfolio as well as his latest detailed transactions.